RELATIONSHIP BETWEEN CLINICAL OUTCOMES AND DISEASE DURATION, EXTENT, AND SEVERITY IN PATIENTS WITH ULCERATIVE COLITIS WHO RECEIVED 6 WEEKS OF TREATMENT WITH GOLIMUMAB

(1) University Of California San Diego, La Jolla, United States

(2) University Of Western Ontario, London, Canada

(3) Centre Hospitalier Universitaire, Lille, France

(4) Mcmaster University, Hamilton, Canada

(5) Alfred Hospital, Melbourne, Australia

(6) University Hospital Gasthuisberg, Leuven, Belgium

(7) Merck & Co., Inc., Whitehouse Station, United States

(8) Janssen R&d, Llc., Spring House, United States



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)